Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy

Conclusion: DBIL emerges as the most potent predictor, and in conjunction with the other four factors, can effectively forecast VID in pediatric patients with epilepsy. This insight can guide the formulation of individualized strategies for the clinical administration of VPA in children.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research